Comparison of Erythrocyte Membrane Lipid Profiles between NAFLD Patients with or without Hyperlipidemia

Wenbin Chen, Shanshan Shao, Hu Cai, Jie Han, Tian Guo, Yilin Fu, Chunxiao Yu, Meng Zhao, Tao Bo, Zhenyu Yao, Jiajun Zhao, Qunye Zhang, Guowang Xu, Chunxiu Hu, Ling GaoInternational Journal of Endocrinology 2020 · DOI

TL;DR

This study investigates how nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia (HL), often co-occurring metabolic disorders, affect the lipid composition of red blood cell (erythrocyte) membranes. They found that while HL significantly alters erythrocyte lipids, NAFLD alone has a less pronounced effect, and the combination of NAFLD and HL leads to a distinct lipid profile, suggesting complex interactions in these conditions.

What Problem Does This Paper Address?

Nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia (HL) are widespread metabolic disorders linked to obesity and overnutrition, significantly increasing the risk of type 2 diabetes and cardiovascular disease. While these conditions often appear together, the precise mechanisms and their combined impact on cellular components are not fully understood. Specifically, how these diseases influence the erythrocyte membrane, a crucial component for oxygen transport and overall cardiovascular health, remains an area needing deeper investigation. Erythrocytes, due to their long lifespan and lack of internal organelles, reflect long-term systemic lipid metabolism. Understanding their membrane lipid profile could offer insights into disease pathogenesis and potential biomarkers. This paper aims to fill this gap by comparing erythrocyte membrane lipid profiles in individuals with NAFLD alone, HL alone, and the combination of both, against healthy controls.

Methods

The researchers employed a comprehensive lipidomics approach using ultra-high-performance liquid chromatography coupled with mass spectrometry (UPLC-Q-TOF/MS) to analyze the lipid profiles of erythrocyte membranes. This technique allows for the identification and quantification of a wide range of lipid species. Lipid extraction from erythrocyte membranes followed a standard Folch method. Statistical analysis involved a one-way ANOVA with a Bonferroni post hoc test to compare the four subject groups (control, NAFLD alone, HL alone, and NAFLD + HL).

Datasets

The study utilized data from 112 subjects enrolled in the REACTION study. After excluding outliers, data from 103 subjects were analyzed. These subjects were categorized into four groups:

  • Normal controls
  • NAFLD alone
  • Hyperlipidemia (HL) alone
  • NAFLD combined with HL (NAFLD + HL)

The groups were matched for age and body mass index (BMI).

Key Insights and Ideas

  • Erythrocyte membranes as a long-term lipid metabolism indicator: The paper highlights that erythrocyte membranes, due to their slow turnover and lack of synthesis capabilities, serve as a valuable window into an individual's long-term systemic lipid metabolism, reflecting conditions over months rather than just recent dietary intake.
  • HL's significant impact on erythrocyte lipids: The study strongly suggests that hyperlipidemia, even when present alone, has a more pronounced effect on erythrocyte membrane lipid composition compared to NAFLD alone.
  • Synergistic vs. distinct effects of NAFLD + HL: The combination of NAFLD and HL doesn't simply add up the effects of each condition. Instead, the NAFLD + HL group exhibits a unique lipid profile, with many lipid species showing decreased levels compared to controls and the HL-alone group, suggesting a complex interplay rather than a simple additive effect.
  • Specific fatty acids as potential indicators: The paper identifies distinct variations in the weight percentage of certain free fatty acids (FFAs), such as myristic acid (MA), erucic acid, and docosahexaenoic acid (DHA), across the different groups, pointing to their potential as biomarkers for these conditions.

Key Results

  • Overall Lipid Changes: Significant alterations in lipid species were observed in the patient groups, particularly in the HL and NAFLD + HL groups.
  • HL Group: Generally showed increased levels of most lipid species in the erythrocyte membrane.
  • NAFLD + HL Group: Exhibited decreased levels of most lipid species, with some exceptions, compared to the control and HL groups.
  • Free Fatty Acids (FFAs):
    • Total FFA content was significantly higher in the HL group compared to NAFLD and NAFLD + HL groups.
  • Myristic acid (FFA 14:0) was elevated in all disease groups compared to controls, but notably decreased in the NAFLD + HL group compared to NAFLD and HL alone.
  • Palmitic acid (FFA 16:0) was decreased in both NAFLD and HL groups compared to controls, but not in the NAFLD + HL group.
  • Erucic acid (FFA 22:1) levels were significantly decreased in all three patient groups compared to controls.
  • Docosahexaenoic acid (DHA, FFA 22:6) was higher in the NAFLD + HL group compared to controls.
  • Phospholipids: The NAFLD + HL group showed significantly decreased levels of total phosphatidylinositol (PI), phosphatidylcholine (PC), and phosphatidylethanolamine (PE) compared to other groups. The HL group showed a significant increase in total PC.
  • Lysophospholipids: The HL group had significantly increased levels of lysophosphatidylcholine (LPC) and lysophosphatidylethanolamine (LPE), while the NAFLD + HL group showed a notable decrease in total LPC.
  • Sphingolipids: The NAFLD + HL group showed a significant decrease in total ceramides (Cer) and sphingomyelins (SM) compared to the control and HL groups.

Limitations and Future Work

  • NAFLD alone influence: The study suggests that the influence of NAFLD alone on erythrocyte membrane lipid profiling is less significant compared to hyperlipidemia.
  • Complex interactions: The distinct lipid profile observed in the NAFLD + HL group, particularly the decrease in many lipid species, suggests that the combined effect is not simply additive and warrants further investigation into the underlying mechanisms.
  • Future Research: The authors suggest that further studies are needed to explore the specific effects of NAFLD or HL on erythrocyte membrane lipid synthesis and metabolism pathways. They also highlight the need to explore the role of specific lipids identified in this study, given their potential roles in cell function and systemic metabolism. The paper also notes that while some individual lipid changes were significant, further research is required to fully elucidate their clinical implications.

Summary updated

Abstract

Nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia (HL) are common metabolic disorders due to overnutrition and obesity. NAFLD is often associated with hyperlipidemia. The aim of this study was to identify and compare the erythrocyte membrane lipids profile in NAFLD patients with or without HL. <i>Methods</i>. A total of 112 subjects (with similar age and body mass index) were divided into four groups: (1) normal controls, (2) NAFLD alone, (3) HL alone, and (4) NAFLD combined with HL (NAFLD + HL). Lipid was extracted from the erythrocyte membrane, and lipid profiles of subjects were analyzed by liquid chromatography mass spectrometry (LC-MS). <i>Results</i>. Data sets from 103 subjects were adopted for lipidomic analysis. Significant changes of lipid species were observed in patient groups, especially in the HL group and NAFLD + HL group. The HL group showed increased level of most lipid species, and decreased level of most lipid species was observed in the NAFLD + HL group. The weight percent of myristic acid, stearic acid, erucic acid, and docosahexaenoic acid also showed distinct variation between different groups. <i>Conclusions</i>. NAFLD, HL, and NAFLD + HL all had an impact on lipid profiling of the erythrocyte membrane. The influence of NAFLD alone is less important compared with HL. Some lipids should be highlighted because of their specific role in cell function and systemic metabolism.
BibTeX
@article{chen2020comparison,
  author = {Wenbin Chen and Shanshan Shao and Hu Cai and Jie Han and Tian Guo and Yilin Fu and Chunxiao Yu and Meng Zhao and Tao Bo and Zhenyu Yao and Jiajun Zhao and Qunye Zhang and Guowang Xu and Chunxiu Hu and Ling Gao},
  title = {{Comparison of Erythrocyte Membrane Lipid Profiles between NAFLD Patients with or without Hyperlipidemia}},
  journal = {International Journal of Endocrinology},
  year = {2020},
  doi = {10.1155/2020/9501826},
}
Figure